Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lumiera Health Inc V.NHP.H

Lumiera Health Inc. is a Canada-based natural health products company. The principal business of the Company is that of selling natural and homeopathic products. The Company specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. It is also developing and commercializing a portfolio of innovative solutions in high growth categories such as sleep-aids and pain management. Its product's portfolio categories such as topical pain relief, sleep, skin care, women's health, & infections. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The Holizen portfolio has over 20 products that cover a range of therapeutic needs, including cardiovascular health; stress relief; bones, joints & muscle mobility; energy and immunity.


TSXV:NHP.H - Post by User

Post by QCRupeeon Oct 26, 2020 3:05pm
166 Views
Post# 31782723

Latest News and financing

Latest News and financing MONTREAL Oct. 23, 2020 /CNW Telbec/ - Mondias Natural Products Inc. (TSXV: NHP) (the "Company" or "Mondias ") announces that it has agreed to amend certain terms of its proposed acquisition of Lumiera Health Innovation Inc. ("Lumiera"), a wholly owned subsidiary of Tetra Bio-Pharma Inc. ("Tetra"), as previously announced on July 23, 2020 here ) (the "Proposed Transaction").
___________

Ok, so I have to ask the obvious question:  Does this financing and re-arrangement (version 5.0) come with a great pair of elbow and kneepads?
Les Boys from downtown montreal and south shore moving money from Tetra to Lumiera to Mondias to Lumiera to Tetra to Mondias now called Lumiera is like following a cow through a field and they really want us to think they are corporate and market geniuses. 

Another financing at a premium to market for such an anaemic little company sends the most arrogant sign to small cap investors.  Unless of course you have solved something so unique that the consumer healthcare market will turn on its head to get a piece of your stock?  I am guessing if it was a great porfolio of promissing products Tetra would have kept it for themselves?

IMHO its time to ask OSC to take a deeper look at this one because its past its best before date.  







<< Previous
Bullboard Posts
Next >>